Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-002368
Filing Date
2023-01-23
Accepted
2023-01-23 16:11:40
Documents
1
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5002
  Complete submission text file 0000899243-23-002368.txt   6917
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Reporting) CIK: 0000850261 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39852 | Film No.: 23544603
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Issuer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)